Argus
•
Mar 08, 2023
OPRX: Lowering target price to $13.00
Summary
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Daily – Vickers Top Buyers & Sellers for 09/02/2026
Sep 02, 2026
•
LUCK, RSG, LINE, CAT, ITT, ANF, SEIC, PETZ, KIDS, THC
PGNY: What does Argus have to say about PGNY?
Sep 02, 2026
•
PGNY
BLFS: Lowering target price to $37.00
Sep 02, 2026
•
BLFS
Technical Assessment: Bullish in the Intermediate-Term
Aug 31, 2026
•
TWLO, MRK
PGNY: What does Argus have to say about PGNY?
Aug 26, 2026
•
PGNY
